Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
ChungAng University Gwangmyeong Hospital, Gyeonggi-do, Gwangmyeon-si, Korea, Republic of
Tanta University, Tanta, El-Gharbia, Egypt
Zhongshan Hospital Fudan university, Shanghai, Shanghai, China
Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey, Antalya, Turkey
Ahmed Uslu, Ankara, Çankaya, Turkey
Clinique Jouvenet, Paris, France
Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
Ahmed Mohamed Soliman, Giza, Egypt
Benha University, Banha, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.